SCHEMBL14640440

SCHEMBL14640440

C#Cc1ccc(Cn2sc(Cl)cc2=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT2B Q92831 13/20 0.50
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA9 Q16790 1/20 0.35
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
G6PD P11413 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
SDHB P21912 1/20 0.33
EP300 Q09472 2/20 0.32
CREBBP Q92793 2/20 0.32
KAT2A Q92830 2/20 0.32
USP4 Q13107 1/20 0.32
USP7 Q93009 1/20 0.32
GSK3A P49840 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL678175 0.81 KAT2B (0.58) KAT2BCA12CA1CA9MAPT
SCHEMBL5593787 0.78 KAT2B (0.47) KAT2BCA12CA1CA9EP300
SCHEMBL80967 0.78 KAT2B (0.58) KAT2BALDH1A1MAPTG6PDPKM
Hydrochloric Acid SCHEMBL9517520 0.76 KAT2B (0.56) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL14640594 0.75 FFAR1 (0.49) KAT2B
SCHEMBL14640429 0.74 KAT2B (0.50) KAT2BCA12CA1CA9ALDH1A1
SCHEMBL5593629 0.73 KAT2B (0.49) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL3655957 0.72 ALDH1A1 (0.57) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL14640430 0.72 KAT2B (0.41) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL14640376 0.71 KAT2B (0.46) KAT2BALDH1A1MAPTG6PDPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001932-A2 SUBSTITUTED ISOTHIAZOLONES AS INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-04 WO disclosed